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Background: The purpose of this study was to determine the reaction mechanism of corticosteroid by analyzing
the expression patterns of neuropeptides (substance P (SP), calcitonin gene related peptide (CGRP)) and of
cytokines (interleukin (IL)-1α, tumor growth factor (TGF)-β) after corticosteroid treatment in lateral epicondylitis.
In addition, we also investigated whether corticosteroid influenced tenocyte viability.
Methods: The corticosteroid triamcinolone acetonide (TAA) was applied to cultured tenocytes of lateral
epicondylitis, and the changes in the mRNA expressions of neuropeptides and cytokines and tenocyte viabilities
were analyzed at seven time points. Quantitative real-time polymerase chain reaction and an MTT assay were used.
Results: The expression of SP mRNA was maximally inhibited by TAA at 24 hours but recovered at 72 hours, and
the expressions of CGRP mRNA and IL-1α mRNA were inhibited at 24 and 3 hours, respectively. The expression of
TGF-β mRNA was not significant. Tenocyte viability was significantly reduced by TAA at 24 hours.
Conclusions: We postulate that the reaction mechanism predominantly responsible for symptomatic relief after
a corticosteroid injection involves the inhibitions of neuropeptides and cytokines, such as, CGRP and IL-1α. However
the tenocyte viability was compromised by a corticosteroid.
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Lateral epicondylitis is histologically characterized by
angiofibroblastic hyperplasia, which includes hypercellu-
larity, neovascularization, increased protein synthesis, and
disorganization of the matrix, but not inflammation [1-6].
However, though many authors have suggested differ-
ent, such as, abnormal vascularity, [7] an imbalance
between vasoconstrictor and vasodilator innervations
[8] micro-tears, [9] and degenerative changes, [10] the
pathogenesis of lateral epicondylitis remains obscure.
Recent studies have suggested that neuropeptides,
such as, substance P (SP) and calcitonin gene related pep-
tide (CGRP), are involved in its pathogenesis [8,11,12]
because inflammatory responses, such as, increased* Correspondence: lsceline@hanmail.net
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reproduction in any medium, provided the orvascular permeability and edematous changes are evident,
though inflammatory cells are absent.
Ljung BO et al. [11] analyzed six patients suffering
from lateral epicondylitis and six healthy volunteers
using immunohistochemistry, and suggested that nerve
fibers showing SP-like and CGRP-like immunoreactivity
were demonstrated at the origin of the extensor carpi
radialis brevis muscle, and neurogenic inflammation
might be implicated in the etiology of lateral epi-
condylitis. Uchio Y et al. [8] also concluded that neuro-
peptides (SP, CGRP) and cytokines (interleukin (IL)-1α,
tumor growth factor (TGF)-β) might contribute to the
pathology of lateral epicondylitis, and suggested that
further studies would be conducted to clarify the inter-
actions between neuropeptides and cytokines. However,
this study was conducted on only 9 patients, and the
analysis was based on immunohistochemistry deter-
mined protein levels.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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epicondylitis, and high short-term success rates have
been reported [13]. However, long-term efficacy is
controversial with high rates of recurrence [14,15]. Fur-
thermore, several reports of tendon weakness or spon-
taneous rupture after corticosteroid injection have been
issued [16].
Before experiment, because corticosteroids are strong
anti-inflammatory agents, we speculated that they might
have a regulatory effect on neuropeptides and cytokines
in the lateral epicondylitis. Furthermore based on the
previously reported studies, we assumed that the mRNA
expression of neuropeptides and cytokines in the teno-
cyte of lateral epicondylitis would be increased in vitro.
Then we analyzed the mRNA expression patterns of
neuropeptides and cytokines using quantitative real-time
polymerase chain reaction (PCR) after treatment with
corticosteroid (triamcinolone acetonide) to determine
the reaction mechanism responsible for the short-term
symptomatic relief afforded by corticosteroid in lateral
epicondylitis. In addition, we examined tenocyte viability
to investigate the detrimental effects of corticosteroid on
tendon structure using a 3-(4,5-dimethylthiazol-2-yl)-




The institutional review board at CHA Bundang hospital
approved this study. After written informed consent was
obtained, twenty-seven patients (11 men and 16 women;
mean 47.5 (SD ± 9.47 years)) treated during the period
2008 - 2012 were studied. All patients underwent partial
resection of the extensor carpi radialis brevis origin with
drilling of the lateral condyle for lateral epicondylitis
because nonoperative treatment had failed. Twenty
patients had lateral epicondylitis on the dominant side,
and seven on the nondominant side. Before operation,
all patients were treated nonoperatively, this included;
cessation of the offending activity, bracing, physiother-
apy (ultrasound, electrical stimulation, manipulation,
stretching, and strengthening exercises), and anti-
inflammatory agents. Twenty of the 27 were given a
local injection of corticosteroid (numbers of injections
ranged from 1 to 3; mean 1.59). No patients received
extracorporeal shock wave therapy or platelet-rich
plasma or botulinum toxin A injection before surgery.
No patient was injected with platelet-rich plasma or
botulinum toxin A.
Diagnoses were made by history taking and based on
physical exam findings, including tenderness over the
tendinous origin close to the lateral epicondyle. Pain was
evoked by resisted extension of the wrist joint, and
symptom duration ranged from 3 to 34 months (meanduration 18.6 months). Alternative diagnoses, such as,
synovitis of the proximal radioulnar joint, entrapment of
the radial nerve, compartment syndrome in anconeus
muscle, arthritis, and other joint disease, were excluded
by clinical examination. In addition, patients with a his-
tory of surgery involving the elbow joint were excluded.
Under general or regional anesthesia, an open ap-
proach (a modification of the Nirschl procedure) was
used, which involved the release of extensor muscle tendon
with decortication at their origin on the lateral. During
each operation, biopsy specimens (7-9 × 7-9 × 5 mm3)
were taken from the extensor carpi radialis brevis tendon,
which appeared dull, gray, friable, and edematous in all 27
patients. One senior surgeon performed the operations and
biopsies.
Healthy tendon
For the control study, we harvested the tendon of exten-
sor carpi radialis brevis from healthy donor, and used it
as the control group. Among the 5 healthy tendons,
three was harvested from men and 2 from women
(mean 45.4 (SD ± 9.47 years)). Then peliminarily we
extracted the RNA and compared the expressions of
neuropeptide and cytokine to that of the diseased ten-
don before cell culture. The detail method of the RNA
extraction is described in the below.
Preliminary study: comparsion of expressions of
neuropeptides and cytokines between the healthy
tenocyte and the diseased tenocyte
We found the relative expressions of SP, CGRP, IL-1α,
and TGF-β in healthy control were extremely limited
compared to the expressions in diseased group (Figure 1).
The relative mRNA expression of SP in diseased tendon
was 51.6 times higher compared to the expression in a
control, CGRP 697.0 times, IL-1α 14.7 times, and TGF-β
179.3 times.
Cell culture
Biopsy tissues were rinsed once in phosphate-buffered
saline (PBS), cut into small pieces under sterile condi-
tions, and centrifuged for 5 minutes at 1000 rpm. Pellets
were digested for 5 hours in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10 mg/ml Col-
lagenaseII (Gibco, Carlsbad, CA, USA) at 37°C in 5%
CO2 at 95% relative humidity (RH), CollagenaseII was
filtered using a MILLEXGP Filter Unit (Millipore, Bed-
ford, MA, USA). After digestion, CollagenaseII was
deactivated by adding fetal bovine serum and the mix-
ture was centrifuged for five minutes at 1000 rpm. The
cells obtained were rinsed with PBS, seeded into a 100 π
dish and cultured with DMEM supplemented with 10%
FBS and 1% Antibiotic-Antimycotic solution (Gibco,
Carlsbad, CA, USA) for one week. The culture medium
Figure 1 Results of quantitative real time polymerase chain reaction of neuropeptide and cytokine between the healthy tenocyte and
the diseased tenocyte. (A) substance P (B) calcitonin gene related peptide (C) interleukin-1α (D) tumor growth factor-β.
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until passage 5 and treated with corticosteroid.
Corticosteroid (triamcinolone acetonide) treatment
Tenocytes were treated with 100 mM triamcinolone
acetonide (TAA) (Dongkwang, Seoul, Korea). After mix-
ing TAA 1 vial (40mg/ml) in 10ml DMEM and 1 ml
normal saline, it was voltexing sufficiently. For incuba-
tion, the mixture 10 ml treated in dish of tendon cell
immediately. At baseline 0 (no TAA treatment), and
after 1, 3, 5, 24, 48, or 72 hours of treatment, cells were
washed with PBS, treated with trypsin-EDTA, and incu-
bated at 37°C in 5% CO2 at 95% RH for five minutes.
Tenocytes were subsequently collected by centrifugation
at 1000 rpm for 5 minutes.
RNA isolation and quantitative real-time PCR
RNA was extracted using an RNeasy Mini Kit (Qiagen,
GmbH, Hilden, German) and quantified using a Nano-
Drop Spectrophotometer (NanoDrop Technologies,
USA). First-strand cDNA synthesis was performed using
a Superscript III kit (Invitrogen, Carlsbad, CA, USA).
cDNA samples were analyzed in triplicate using the Bio-
Rad CFX96 Real-Time PCR Detection System. Briefly,
1 μg of total RNA was amplified using the Taq ManGene Expression Assay (Applied Biosystems, UK) for the
analyses of GAPDH (ABI code: Hs99999905_m1), SP
(ABI code: Hs00243225_m1), CGRP (ABI code:
Hs00265194_m1), IL-1α (ABI code: Hs00174092_m1),
and TGF-β (ABI code: Hs00998133_m1) respectively.
The PCR reaction mix had a volume of 20 μl and con-
tained 10 μl 2X TaqMan master mix (Applied Biosys-
tems, UK), 1 ul primer and probe kit (Applied
Biosystems, UK), 1 μl cDNA, and 8 μl of diethylenepyro-
carbonate (DEPC) water. The reverse transcription con-
ditions used were as follows; 50°C for 2 minutes, 95°C
for 10 minutes, followed by 40 cycles of 95°C for 15 sec-
onds and 60°C for 1 minute. RNA levels were quantified
at least three times. Transcript levels were normalized
versus GAPDH expression, and gene expression was
calculated using 2-ΔΔCt.
MTT assay
Cell viabilities were measured using an MTT assay. The
cells were incubated with TAA for 0 (baseline), 1, 3, 5,
24, 48, or 72 hours. Tendon cells were seeded into 96-
well plates at a density of 5 × 103 cells per well and incu-
bated at 37°C and 95% RH in 5% CO2. After incubation,
10 μl of MTT (Sigma, St. Louis, MO) was added to each
well, and plates were incubated for 3 hours at 37°C in
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MO) was then added and agitated for 30 minutes. The
optical densities were measured using an ELISA reader
(Molecular Devices Emax) at an excitation wavelength
of 530 nm and an emission wavelength of 590 nm.
Readings were taken at least three times at all times for
each patient.
Statistical analysis
Data were collected and analyzed using R software (ver-
sion 2.11.1; R Foundation for Statistical Computing,
Vienna, Austria). To analyze the time-dependent effects
of TAA, repeated measures ANOVA was used to deter-
mine whether the relative mRNA expressions and op-
tical densities were significantly different at the seven
time points. To analyze quantitative real-time PCR
results, we arbitrarily set mRNA expression at baseline
to one. In addition, we assessed the relationships be-
tween the five variables, that is, the relative expression
levels of the mRNAs of SP, CGRP, IL-1α, and TGF-β,
and tenocyte viability at each time point by Pearson's
correlation analysis, and calculated Pearson's correlation
coefficients (r). Differences were considered statistically
significant when P values were less than 0.05 (p < 0.05).
Results
All of the statistical analyses at each time point followed
a normal distribution and are summarized in Table 1.
Effects of TAA on the expressions of the mRNAs of
Neuropeptides (Figure 2)
SP
The SP mRNA expression differed between the seven
time points of the protocol (p = 0.0078, repeated mea-
sures ANOVA), and its expression was substantially
decreased after 1, 24, and 48 hours of TAA treatment
versus baseline (p < 0.0001, < 0.0001, = 0.0005, each),
but followed by a minimal increase from 48 to 72 hours.Table 1 Changes in gene expression of neuropeptides, cytoki
triamcinolone acetonide treatment at seven time points (0, 1
No TAA After
0 hr 1 hrs 3 hrs 5 hrs
SP 1.000 0.527± 0.154 0.881 ±0.326 0.652 ±0.
CGRP 1.000 1.119± 0.336 1.197 ±0.308 0.958 ±0.
IL-1α 1.000 1.183 ±0.35 0.342 ±0.168 0.185± 0.
TGF-β 1.000 1.108 ±0.225 1.132 ±0.219 1.186±0.2
Tenocyte viability 0.582 0.491± 0.038 0.502 ±0.041 0.467 ±0.
The values are given either as mean ± SD.
SP = Substance P.
CGRP = Calcitonin gene related peptide.
IL-1α = Interleukin-1α.
TGF-β = Tumor growth factor-β.
TAA = Triamcinolone acetonide.
*Repeated measures ANOVA.However, values at 3 and 5 hours were not significantly
different from baseline.
CGRP
Repeated measures ANOVA revealed that CGRP expres-
sion differed at the seven treatment times (p < 0.0001).
The mRNA expression started to reduce substantially
after 24 hours of TAA treatment. The gene expression
of CGRP at 24, 48, and 72 hours was significantly dimin-
ished by 64.1% at 24 hours, by 73.2% at 48 hours, and
67.0% at 72 hours.
Effects of TAA on the expressions of the mRNAs of
cytokines (Figure 3)
IL-1α
The IL-1α mRNA expressions were significantly affected
by TAA at all treatment times (p < 0.0001, by repeated
measures ANOVA). Its expression was significantly
reduced after 3 hours of incubation with TAA (p <
0.0001) and this was followed by a further gradual
decrease to 72 hours.
TGF-β
The TGF-β mRNA expressions also differed at the seven
treatment times (p = 0.0187, by repeated measures
ANOVA). However, no values were different from base-
line, but it was only differed between the expression at 5
and 72 hours after TAA application (p = 0.0341).
Effects of TAA on tenocyte viability (Figure 4)
After TAA treatment, the optical densities gradually
decreased (p < 0.0001, by repeated measures ANOVA).
No significant differences were observed between teno-
cyte viabilities at 0, 1, 3, and 5 hours and at baseline, but
at 24, 48 and 72 hours tenocyte viabilities were reduced
by 30.4, 39.3, and 47.4%, respectively, versus baseline
(p < 0.0001, < 0.0001, < 0.0001, respectively).nes and in optical density of tenocyte viability after
, 3, 5, 24, 48, 72 hours)
TAA treatment Statistical
significance (p)*24 hrs 48 hrs 72 hrs
246 0.412±0.166 0.527 ±0.189 0.696 ±0.235 0.0078
312 0.359 ±0.153 0.268 ±0.161 0.330 ±0.164 < 0.0001
091 0.210 ±0.166 0.107± 0.114 0.053 ±0.027 < 0.0001
49 1.015±0.198 0.859 ±0.234 0.772 ±0.228 0.0187
049 0.405 ±0.042 0.353 ±0.033 0.306 ±0.021 < 0.0001
Figure 2 Results of quantitative real time polymerase chain reaction of neuropeptide after triamcinolone acetonide treatment
(0, 1, 3, 5, 24, 48, 72 hours). (A) Changes in mRNA expressions of substance P (B) Changes in mRNA expressions of calcitonin gene related
peptide **Baseline *Statistically significant values compared to baseline.
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Pearson's correlation analysis at each time point revealed
no correlation between the five variables (SP, CGRP,
IL-1α, TGF-β, tenocyte viability) after 0, 1, 3, 5, 24,
and 48 hours of TAA treatment (Figure 5). However,
at 72 hours, a positive correlation was found between
the expressions of CGRP and IL-1α (p = 0.0184 and r =
0.45) (Figure 6).
Discussion
The present study was undertaken to determine mole-
cular mechanism responsible for the effects of cortico-
steroid on the neuropeptide and cytokines in lateral
epicondylitis. In addition, we examined tenocyte viabil-
ities to investigate the detrimental effects corticosteroid
has on tendon integrity.
The previous studies about neurogenic inflammation and
lateral epicondylitis have used an immunohistochemical
approach. However, immunohistochemical studies have
some disadvantages, such as, photobleaching, markerFigure 3 Results of quantitative real time polymerase chain reaction
48, 72 hours). (A) Changes in mRNA expressions of interleukin-1α (B) Cha
*Statistically significant values compared to baseline.infidelity, and lack of specificity. Furthermore, they rely
on qualitative rather than quantitative assessments of
effects, and even when results are scored, intra observer
variability is problematic. Therefore, in the present study,
the mRNA expressions of SP, CGRP, IL-1α, and TGF-β
were determined by quantitative real-time PCR.
Before operations, 20 patients were treated with local
TAA injection. Five patients were injected once, 7
patients twice, and 8 patients three times. These local
injections may have influenced outcomes because cortico-
steroid infiltration has been reported to cause the necrosis
of tendon collagen [17]. However, surgery was performed
a minimum of six months after last injections when the
patient had sustained or recurred tenderness over the
lateral side of the elbow. Thus, it appears reasonable to
assume that the effects of previous local injections would
have been minimal, as has mentioned previously [8,11].
To decide on the concentration of TAA to use in the
present study, we examined the effects of TAA at 25, 50,
and 100 mM on tenocytes in small number of cases, andof cytokine after triamcinolone acetonide treatment (0, 1, 3, 5, 24,
nges in mRNA expressions of tumor growth factor-β **Baseline
Figure 4 Changes of tenocyte viability after triamcinolone
acetonide treatment (0, 1, 3, 5, 24, 48, 72 hours) by MTT assay.
**Baseline *Statistically significant values compared to baseline.
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peptides, cytokines and tenocyte viabilities. However, no
dose-dependent effect was observed due to the poor
solubility of TAA in culture medium, as described by
Herbert et al. [14] Wong et al. [15] reported medical
preparations of TAA used for local injections have con-
centrations over 10 mM, and added that tissue levels
immediately after a local glucocorticoid injection would
be near that in preparations, and thus, we treated teno-
cytes with TAA at 100 mM (the same concentration
used for injection at outpatient clinics). Furthermore
we did not add any solvent except saline. In outpatient
department (in vivo), TAA was injected only with
normal saline or lidocain.
The time points used in the present study were
obtained by reviewing the literature. In several studies,
tenocyte viability was analyzed after 2 to 14 days of
incubation with corticosteroid [14,15]. However, we
considered that neuropeptides and cytokines would
response to corticosteroid rapidly because steroid injec-
tion in outpatient clinics sometimes improves pain
within 24 hours. Accordingly, we performed analysis at
7 time points, at 0 hours (baseline), and after 1, 3, 5, 24,
48, and 72 hours TAA treatment to detect the early
effects of corticosteroid.
The peripheral nervous system, acting through neuro-
peptides, not only relays sensory information to the
central nervous system, but also plays an effector role in
inflammatory, proliferative, and reparative processes
after injury. Of these neuropeptides, SP and CGRP are
known to be mainly involved in neurogenic inflamma-
tion. Not only do SP and CGRP transmit nociceptive in-
formation to the spinal cord, but they are also involved
in vasodilation and plasma extravasation [18].It was previously postulated that the level of SP in-
nervation within tendon tissue is limited. However, re-
cent studies have investigated the expressions of SP and
neurokinin-1 receptor in tenocytes, and found that their
expression levels are higher in tenocytes in human
Achilles tendinosis [19]. In 2010, Lui et al. [20] also
reported that the expressions of SP and CGRP are
increased in tendon fibroblasts, chondrocyte-like cells,
and calcific deposits after collagenase-induced tendon
injury. Therefore, we assumed that the cultured tenocyte
from lateral epicondylitis has the abundant expression of
neuropeptide mRNA in contrast to the normal or un-
affected tenocyte which express the neuropeptide mRNA
minimally. We also hypothesized that the mRNAs of SP
and CGRP might be over-expressed in the tenocytes of
lateral epicondylitis in vitro, and preliminarily performed
the analysis of mRNA expression from healthy tenocyte,
and compared the results with the diseased group. Actu-
ally it is not easy to harvest normal healthy tenocyte
from human being, consequently the sample number
of control was limited to only 5 tendons. However,
we found the expressions of neuropeptide and cytokine
in control were significantly lower than that of the
diseased group (Figure 1). Furthermore several reports
have been already demonstrated the increased expres-
sion of neuropeptide in the tenocyte of lateral epicondyl-
itis and concluded that the neuropeptide might be the
important factor in the pathogenesis of lateral epicondyl-
itis [7,20]. We also did determine the increased expres-
sions of neuropeptides in diseased tenocytes, and we
found that the expression of CGRP was significantly
inhibited by corticosteroid.
Although the reaction mechanisms responsible for the
effects of corticosteroids are not fully understood, it has
been reported that corticosteroids can modulate cyto-
kines and other inflammatory mediators [21]. Corticos-
teroids bind to specific intracellular receptors that
function as ligand-induced transcription factors, and
thus, modulate the expressions of particular target genes.
Furthermore, the expressional levels of various cyto-
kines, such as, IL-1, IL-2, IL-6, IL-8, and interferon-γ are
decreased by corticosteroids [22].
Interleukin-1α is an initial phase cytokine responsible
for inflammation. We observed that the mRNA expres-
sion of IL-1α significantly decreased by 65.8% at 3 hours
and then gradually decreased by 94.7% after treatment
with TAA for 72 hours. We suppose that these changes
are responsible for the symptomatic improvement shown
after corticosteroid injection in lateral epicondylitis.
TGF-β is one of the repair-phase cytokines and is
involved in the synthesis and deposition of collagen, and
scar formation after tendon transection [23]. The effects
of corticosteroid on TGF-β are controversial. Some
researchers have reported that steroids upregulate TGF-
Figure 5 Pearson’s correlation analysis between between 5 variables at each time. Analysis reveals no correlation except the CGRP
against interleukin-1α after triamcinolone acetonide treatment 72 hours after triamcinolone acetonide treatment. Left lower half: Corrgram
shows the correlations by the color and intensity. Right upper half: Typical scatter plot. SP = Substance P, CGRP = Calcitonin gene related
peptide, IL-1α = Interleukin-1α, TGF-β = Tumor growth factor-β, MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay.
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that TAA inhibits the production of TGF-β by human
dermal fibroblasts.
In this study, the TGF-β mRNA expression was
slightly higher after treatment for 5 hours without statis-
tical significance, and then started to be inhibited at 24.
We hypothesize that these responses are reflective of
secondary changes associated with compromised teno-
cyte viability. However, Pearson's correlation analysis did
not reveal any significant correlation.
Steroid injections are also known to decrease neuro-
genic edema, and to influence the effects and levels of
SP and CGRP [8,25]. Ihara et al. [26] studied the effect
of glucocorticoids on the regulation of substance P
receptor mRNA in rat pancreatic acinar AR42J cells by
northern blot analysis using cloned cDNA. It was found
that the expression of substance P receptor mRNA was
selectively and negatively regulated by glucocorticoid.
In the present study, treatment with TAA for 24 and
48 hours significantly reduced the expression of SP
mRNA, and subsequently its expression increased
slightly. These results suggest that SP is temporarily
inhibited by corticosteroid.On the other hand, CGRP mRNA expression showed
a rapid and significant decrease at 24 hours, and
this was not recovered. Thus, we speculate that the
inhibitionof CGRP is probably a more significant mole-
cular event than the inhibition of SP in reaction mech-
anism responsible for the effects of corticosteroid in
lateral epicondylitis.
In addition to the mRNA expressions of neuropeptides
and cytokines, we examined the effect of TAA on teno-
cyte viability using an MTT assay. In particular, steroids
are known to induce adverse histologic changes and
reduce the mechanical strengths of tendons [15,27]. In
the present study, TAA was found to gradually reduce
tenocyte viability by 39.3% at 48 hours and by 47.4% at
72 hours versus baseline.
It could be questioned that the changes of tenocyte
viability could affect to the expression of neuropeptide
and cytokine. However, statistically the tenocyte viability
was decreased significantly 24 hours after TAA treat-
ment. But, although the CGRP was decreased signifi-
cantly 24 hours after TAA treatment, substance P and
interleukin was decreased significantly 1 and 3 hours
after TAA treatment (before 24 hours). So we
Figure 6 Correlation plots of mRNA expressions for CGRP against
interleukin-1α by Pearson’s correlation analysis at 72 hours after
triamcinolone acetonide treatment. The lines of best fit are
indicated on the graphs. CGRP = Calcitonin gene related peptide.
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changes of neuropeptide and cytokine were not affected
by the tenocyte viability.
Several studies have addressed the relationship be-
tween neuropeptides and cytokines because neuropep-
tides are probably potent stimulators of proinflammatory
cytokine generation [28]. Our study demonstrates a
significant positive correlation between CGRP and IL-1α
(p = 0.0184 and r = 0.45) after 72 hours of TAA treat-
ment. These results support the idea that the neuropep-
tide, CGRP might have effect on the synthesis of IL-1α
without inflammatory cell infiltration in this lesion and
that neurogenic inflammation underlies the pathogenesis
of lateral epicondylitis.
Summarizing, the mRNA expressions of neuropeptides
were detected in the lesions of lateral epicondylitis, and
TAA treatment was found to inhibit the expressions of the
mRNAs of neuropeptides, especially of CGRP, in 24 hours,
and the expressions of cytokine mRNAs, especially that of
IL-1α, in 3 hours. Furthermore, the expression of SP
mRNA was maximally inhibited by TAA at 24 hours and
recovered at 72 hours, whereas the expression of TGF-β
mRNA was slightly increased versus baseline until 5 hours,
and subsequently decreased. In addition, MTT assays
showed that tenocyte viability was significantly decreased
by TAA at 24 hours, and a significant positive correlation
was found between the relative mRNA expressions of
CGRP and IL-1α after 72 hours of TAA treatment.
Conclusions
We postulate that the reaction mechanism of cortico-
steroid treatment in lateral epicondylitis is associatedwith the inhibitory effect on not only cytokines but also
neuropeptides such as, CGRP. However it should be
noted that the tenocyte viability is simultaneously com-
promised. Furthermore our results revealed that CGRP
and IL-1α had significant positive correlation, and this
supports that neurogenic inflammation might play a role
in the pathogenesis of lateral epicondylitis.
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